Bharat Biotech expects COVID-19 vaccine to be atleast 60% effective, launch likely in Q2 of 2021

DNA

22 Nov 2020 0 shares 1 views

DNA

Published 22 Nov 2020

Bharat Biotech launched its third phase trials of Covaxin in Haryana on November 20. It had applied for permission to the DGCI on October 2

India in talks with Moderna for its COVID-19 vaccine candidate: Report

India is in dialogue with the US-based biotech giant Moderna over the progress in the clinical trials of its coronavirus vaccine..

Mid-Day 17 Nov 2020

Even as India's first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech on Monday..

Mid-Day 16 Nov 2020